Donghua Shi

Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials

Donghua Shi, Ahmed O. Kaseb, Xingxing Qi et al. · Clinical Cancer Research · 2020 · 366 citations

Life Sciences, Immunology, Oncology +17

A phase I study of anti-GPC3 chimeric antigen receptor modified T cells (GPC3 CAR-T) in Chinese patients with refractory or relapsed GPC3+ hepatocellular carcinoma (r/r GPC3+ HCC).

Bo Zhai, Donghua Shi, Huiping Gao et al. · Journal of Clinical Oncology · 2017 · 83 citations

Life Sciences, Immunology, Oncology +17

Efficacy and safety of lenvatinib plus gefitinib in lenvatinib-resistant hepatocellular carcinomas: a prospective, single-arm exploratory trial

Dan Cui, Lei Xia, Donghua Shi et al. · Signal Transduction and Targeted Therapy · 2024 · 16 citations · Full text

Medicine, Oncology, Pharmacology +17

Long-term results of percutaneous microwave ablation for colorectal liver metastases

Zhenyu Wang, Jiachang Chi, Donghua Shi et al. · HPB · 2020 · 15 citations · Full text

Medicine, Oncology, Surgery +15

Ultrasound-guided percutaneous microwave ablation for hepatocellular carcinoma originating in the caudate lobe

Yuan Peng, Dan Cui, Weijian Li et al. · Journal of Cancer Research and Therapeutics · 2021 · 11 citations · Full text

Medicine, Oncology, Surgery +17